Michael D. Burkitt

This study identifies clarithromycin as a potential therapeutic for inflammatory bowel disease through in-silico drug repositioning and experimental validation of its effects on NF-κB signaling.

This study shows that long-term iron deficiency and supplementation affect gut microbiota but not chronic colitis, while exacerbating acute DSS-induced colitis.